Clinically-Observed FOXA1 Mutations Upregulate SEMA3C through Transcriptional Derepression in Prostate Cancer

Researchers characterized FOXA1 alterations with respect to its regulation of semaphorin 3C (SEMA3C). They revealed that FOXA1 alterations led to elevated levels of SEMA3C both in prostate cancer specimens and in vitro.